FDA Inspection 1295512 — Alexander Babatunde Olawaiye, M.D
The FDA completed an inspection of Alexander Babatunde Olawaiye, M.D on November 19, 2025 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 19, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Pittsburgh, PA (United States)
Additional Details
Clinical Investigator (CI)